In TRIUMPH-2, participants with obesity and type 2 diabetes taking retatrutide 12 mg lost an average of 49.6 lbs (20.8%) over ...

Researchers will gain an integrated synthetic data foundation and an advanced custom search platform to support reaction data ...

Piramal Pharma Solutions is investing over $5.3 million in its Aurora drug substance facility to upgrade site infrastructure.

Discontinuations by stated reason and by phase, APAC sponsors, 1 January to 30 September 2026. Source: BioPharma APAC ...

Hengrui Pharma announced that it has entered into a license agreement with Novo Nordisk (Novo) for HRS-1596, a phase I-ready ...

Link Cell Therapies ("Link"), an oncology cell therapy company utilizing its proprietary logic-gating technology to develop ...

It has been evaluated across multiple clinical studies in patients with CLL/SLL who were either previously treated with a ...

NouvSight001 secures regulatory clearances from the US FDA and China’s NMPA for clinical development in retinitis pigmentosa, ...

The Stockholm Region deployment marks another important milestone in Lunit's expansion across Europe, demonstrating how ...

How this list was built Scope. Every biotech initial public offering with a first trading day between 1 January and 24 ...

Continued investment in Vetter’s broader operational infrastructure accompanies the expansion of its manufacturing capacity.

Collaboration combines Samsung NeuroLogica’s mobile CT expertise with Accuray’s robotic radiosurgery and motion management ...